Patient Reported Outcomes in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata

被引:0
|
作者
Mesinkovska, Natasha Atanaskova [1 ]
Senna, Maryanne Makredes [2 ]
Mostaghimi, Arash [3 ]
King, Brett [4 ]
Hamilton, Colleen [5 ]
Cassella, James [6 ]
机构
[1] Univ Calif Irvine, Clin Res, Irvine, CA USA
[2] Lahey Hosp & Med Ctr, Hair Loss Ctr Excellence, Burlington, MA USA
[3] Brigham & Womens Hosp, Dept Dermatol, Boston, MA USA
[4] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT USA
[5] Concert Pharmaceut, Clin Operat, Lexington, MA USA
[6] Concert Pharmaceut, Lexington, MA USA
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:AB204 / AB204
页数:1
相关论文
共 41 条
  • [41] ANALYSIS OF PATIENT-REPORTED OUTCOMES FROM THE LUME-LUNG 1 TRIAL: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 STUDY IN SECOND-LINE ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Novello, Silvia
    Mellemgaard, Anders
    Kaiser, Rolf
    Douillard, Jean-Yves
    Orlov, Sergei
    Krzakowski, Maciej
    Von Pawel, Joachim
    Gottfried, Maya
    Bondarenko, Igor
    Liao, Meilin
    Barrueco, Jose
    Gaschler-Markefski, Birgit
    Griebsch, Ingolf
    Reck, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1207 - S1207